J.P. Morgan keeps EUR 23.50 target for Philips stock

Published on 10/20/2026 at 09:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sonicare formed a 12-expert board on October 8, 2026. Philips stock costs EUR 23.07 on October 20, 2026, 16.71 percent below EUR 27.70.

Operational and valuation signals

Philips formed a 12-expert Sonicare board on October 8, 2026.
Second-quarter revenue reached EUR 4.36 billion versus EUR 4.34 billion a year earlier.
Philips stock trades at EUR 23.07 at 9:06 a.m. CEST at Lang & Schwarz on October 20, 2026.

Isometrische 3D-Grafik der Wertschöpfungskette von Fabrik bis Weltvertrieb — Koninklijke Philips N.V. (NL0000009538) illustriert isometrische Wertschöpfungskette von Fabrik über Lager bis Medizingeräte-Vertrieb weltweit, Illustration mit AI erstellt.

Philips (ISIN NL0000009538) has a J.P. Morgan Hold rating with a EUR 23.50 price target, according to Markets Insider on October 9, 2026. The stock was trading at EUR 23.07 at Lang & Schwarz at 9:06 a.m. CEST on October 20, 2026. The latest analyst signal leaves the target 1.86 percent above that euro quotation.

Q2 revenue sets the baseline

Philips reported EUR 4.36 billion in revenue and EUR 384 million in net profit for the second quarter of 2026. Markets Insider said the revenue figure compared with EUR 4.34 billion and net profit of EUR 240 million in the year-earlier quarter. Revenue therefore increased by EUR 20 million, while net profit rose by EUR 144 million.

What does the target imply?

The EUR 23.50 target is close to the current euro quotation, leaving a 1.86 percent gap rather than a wide valuation reset. Markets Insider reported that analyst David Adlington maintained the Hold rating alongside the target. A cautious rating and a modest target gap put operating delivery ahead of a broad revaluation story.

Three dated signals shape the case

Philips reported EUR 4.36 billion of second-quarter revenue on July 28, 2026, compared with EUR 4.34 billion a year earlier, as reported by Markets Insider. On October 8, 2026, Royal Philips announced a Philips Sonicare Global Clinical Advisory Board with 12 dental experts, according to the company's Philips release. On October 9, 2026, J.P. Morgan kept its Hold rating and EUR 23.50 target, as reported by Markets Insider.

Stock stays near the target

The combination of higher year-over-year net profit and a target only EUR 0.43 above the market quotation gives Philips stock a mixed but measurable setup. The Sonicare board adds clinical input to Oral Healthcare, while the valuation signal keeps attention on execution in the company's health technology businesses.

Philips was trading at EUR 23.07 at Lang & Schwarz on October 20, 2026, at 9:06 a.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Philips stock.